Kidney Medicine (Mar 2021)

TAFRO Syndrome With Kidney Involvement: A Case Series of Patients With Kidney Biopsies

  • Keiki Shimada,
  • Takaya Sasaki,
  • Masahiro Okabe,
  • Kentaro Koike,
  • Daisuke Takahashi,
  • Risa Terashima,
  • Yu Honda,
  • Naoto Matsumoto,
  • Akira Fukui,
  • Masahiro Ishikawa,
  • Nobuo Tsuboi,
  • Takashi Yokoo

Journal volume & issue
Vol. 3, no. 2
pp. 286 – 293

Abstract

Read online

TAFRO (thrombocytopenia, anasarca, fever, reticulin myelofibrosis/renal insufficiency, and organomegaly) syndrome is a systemic inflammatory disease sharing some features with Castleman disease and POEMS (polyneuropathy, organomegaly, endocrinopathy, monoclonal protein, and skin changes) syndrome in relation to abnormal secretions of interleukin 6 and vascular endothelial growth factor. The kidney is a main target organ of TAFRO syndrome but the kidney histopathology associated with TAFRO syndrome is yet to be completely defined. We report 3 TAFRO syndrome cases with different clinical courses in which kidney biopsies were performed. In all 3 cases, kidney biopsies showed similar glomerular lesions of diffuse global swelling of the endothelium and expansion of subendothelial spaces, consistent with severe glomerular endothelial injury. Case 3 showed an additional finding of focal tubulointerstitial injury characterized by marked plasma cell infiltration, which was absent in the other 2 cases. Clinical symptoms in cases 1 and 2, which had lower disease severity scores of TAFRO syndrome, were effectively treated with the administration of corticosteroids or a combination of corticosteroids and cyclosporine A. Case 3, with a higher disease severity score, had an aggressive clinical course that was refractory to corticosteroids and tocilizumab; the patient ultimately died of multiple organ failure. In all 3 cases, kidney biopsy provided indications for the diagnosis process and clinical management of TAFRO syndrome.

Keywords